Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 24.36 USD 1.29%
Market Cap: 3.3B USD

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Perrigo Company PLC

Revenue
4.4B USD
Cost of Revenue
-2.8B USD
Gross Profit
1.6B USD
Operating Expenses
-1.3B USD
Operating Income
237.9m USD
Other Expenses
-397.6m USD
Net Income
-159.7m USD

Margins Comparison
Perrigo Company PLC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IE
Perrigo Company PLC
NYSE:PRGO
3.3B USD
36%
5%
-4%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-3%
-83%
-79%
US
Eli Lilly and Co
NYSE:LLY
712.2B USD
81%
35%
20%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
3%
-4%
DK
Novo Nordisk A/S
CSE:NOVO B
2.6T DKK
85%
44%
35%
US
Johnson & Johnson
NYSE:JNJ
353.9B USD
69%
28%
17%
US
Merck & Co Inc
NYSE:MRK
243.5B USD
77%
34%
19%
CH
Roche Holding AG
SIX:ROG
218.2B CHF
73%
32%
20%
UK
AstraZeneca PLC
LSE:AZN
172.1B GBP
82%
21%
13%
CH
Novartis AG
SIX:NOVN
176.8B CHF
75%
31%
35%
IE
Endo International PLC
LSE:0Y5F
148.3B USD
68%
11%
-126%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Perrigo Company PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IE
Perrigo Company PLC
NYSE:PRGO
3.3B USD
-3%
-1%
2%
2%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-441%
-47%
-108%
-64%
US
Eli Lilly and Co
NYSE:LLY
712.2B USD
66%
13%
33%
19%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
-2%
2%
2%
DK
Novo Nordisk A/S
CSE:NOVO B
2.6T DKK
89%
27%
75%
35%
US
Johnson & Johnson
NYSE:JNJ
353.9B USD
20%
8%
18%
13%
US
Merck & Co Inc
NYSE:MRK
243.5B USD
28%
11%
25%
20%
CH
Roche Holding AG
SIX:ROG
218.2B CHF
40%
13%
29%
22%
UK
AstraZeneca PLC
LSE:AZN
172.1B GBP
17%
6%
14%
12%
CH
Novartis AG
SIX:NOVN
176.8B CHF
45%
17%
24%
16%
IE
Endo International PLC
LSE:0Y5F
148.3B USD
70%
-51%
5%
6%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.